| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.661 | 3.652 | - | 18.125 | 40.580 | 26.973 | 55.694 | 224.663 | - | - |
| Total Income - EUR | 2.661 | 3.652 | - | 18.125 | 40.580 | 26.973 | 55.695 | 224.664 | - | - |
| Total Expenses - EUR | 652 | 415 | - | 1.394 | 6.949 | 13.278 | 21.011 | 83.914 | - | - |
| Gross Profit/Loss - EUR | 2.009 | 3.237 | - | 16.731 | 33.632 | 13.695 | 34.684 | 140.750 | - | - |
| Net Profit/Loss - EUR | 1.930 | 3.128 | - | 16.187 | 32.414 | 13.439 | 34.172 | 138.615 | - | - |
| Employees | 0 | 0 | - | 0 | 1 | 1 | 1 | 1 | - | - |
Check the financial reports for the company - Mitraortic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16 | 0 | - | 0 | 0 | 3.133 | 23.735 | 17.531 | - | - |
| Current Assets | 2.425 | 3.834 | - | 24.501 | 56.867 | 65.745 | 70.717 | 239.505 | - | - |
| Inventories | 0 | 0 | - | 96 | 0 | 0 | 16 | 62.764 | - | - |
| Receivables | 0 | 0 | - | 0 | 0 | 0 | 358 | 25.235 | - | - |
| Cash | 2.425 | 3.834 | - | 24.405 | 56.867 | 65.745 | 70.344 | 151.507 | - | - |
| Shareholders Funds | 1.975 | 3.172 | - | 23.806 | 55.759 | 68.141 | 92.716 | 231.619 | - | - |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 467 | 662 | - | 695 | 1.108 | 736 | 1.736 | 25.418 | - | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mitraortic Srl